Project Farma and Precision ADVANCE

Anshul Mangal

President
Project Farma and Precision ADVANCE
  • Comprehensive Support for Innovators: Offers a wide range of services tailored to mRNA developers, accelerating research and clinical development, streamlined manufacturing processes, and effective value demonstration and market access strategies.
  • Pioneering mRNA Manufacturing Expertise: Involved in the development of some of the industry’s first mRNA manufacturing facilities, showcasing a deep understanding of mRNA therapy production.
  • Extensive Novel Therapeutics Portfolio: Precision Medicine Group brings a wealth of experience and a proven track record in the mRNA sector and novel therapeutics with over 3500+ team members and a clientele of over 150 partners, including mRNA vaccines and therapies.